Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia.

ABSTRACT:

Background

As the global coronavirus pandemic (COVID-19) spreads across the world, new clinical challenges emerge in the hospital landscape. Among these challenges, the increased risk of coinfections is a major threat to the patients. Although still in a low number, due to the short time of the pandemic, studies that identified a significant number of hospitalised patients with COVID-19 who developed secondary fungal infections that led to serious complications and even death have been published.

Objectives

In this scenario, we aim to determine the prevalence of invasive fungal infections (IFIs) and describe possible associated risk factors in patients admitted due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Patients/methods

We designed

SUBMITTER: Segrelles-Calvo G 

PROVIDER: S-EPMC7753478 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature